Regulatory class action lawsuit

Zynex Faces Class Action Over Fraudulent Overbilling

Analysis based on 8 articles · First reported Apr 14, 2026 · Last updated Apr 17, 2026

Sentiment

-40

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The class action lawsuit against Zynex for alleged fraudulent overbilling is expected to negatively impact its stock price and market reputation. This event highlights the risks associated with companies engaging in aggressive sales tactics that may violate regulations, potentially leading to increased scrutiny on similar firms.

Medical Devices Legal Services

Event Summary

A class action lawsuit has been filed against Zynex and its officers by Bronstein, Gewirtz & Grossman, LLC, on behalf of investors who purchased Zynex securities between February 25, 2021, and December 15, 2025. The lawsuit alleges that Zynex engaged in a fraudulent overbilling scheme, shipping products in excess of need and inflating its revenue. This practice drew scrutiny from insurers like United States===Tricare and led to a separate lawsuit by The Travelers Companies seeking over $23 million in damages. The complaint asserts that Zynex's management prioritized aggressive sales over compliance, leading to illegal overbilling and a high likelihood of adverse consequences, including removal from insurer networks and government penalties. Investors have until April 21, 2026, to request to be appointed as lead plaintiff.

Key Actions

100 Bronstein, Gewirtz & Grossman, LLC filed a class action lawsuit Zynex

90 Zynex shipped products in excess of need and inflated revenue

80 The Travelers Companies commenced an action alleging fraudulent overbilling Zynex

Entities Involved

stock

Zynex

Zynex is facing a class action lawsuit alleging fraudulent overbilling and inflated revenue, which has led to scrutiny from insurers and a lawsuit from Travelers. This could result in significant financial penalties and removal from insurer networks, severely impacting its business and stock price.

Importance 100 Sentiment -80

priv

Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman, LLC is the law firm that filed the class action lawsuit against Zynex, seeking to recover damages for investors. This event enhances their reputation as an investor-rights law firm.

Importance 70 Sentiment 60

stock

The Travelers Companies

The Travelers Companies commenced an action against Zynex, alleging a fraudulent overbilling scheme and seeking over $23 million in damages. This action highlights their role in uncovering the alleged fraud.

Importance 50 Sentiment 20

per

Peretz Bronstein

Peretz Bronstein is the founding partner of Bronstein, Gewirtz & Grossman, LLC, and is leading the class action lawsuit against Zynex. His involvement underscores the firm's commitment to investor protection.

Importance 40 Sentiment 50

govactor

United States===Tricare

United States===Tricare is mentioned as an insurer that scrutinized Zynex's practice of filing false claims, indicating regulatory and financial oversight concerns.

Importance 30 Sentiment 0

Relationships

Bronstein, Gewirtz & Grossman, LLC related ↔ Zynex

Peretz Bronstein related ↔ Bronstein, Gewirtz & Grossman, LLC

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard